Towa Pharmaceutical Co., Ltd. (TWAPF)
Towa Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Osaka, JP. The stock last traded at $25.98, up 0.00% on the session, giving a market capitalisation of $1.28B. On trailing twelve-month figures it carries a trailing P/E of 22.03, a net margin of 3.0%. Its beta of -0.09 implies it has historically moved less than the broad market.
Operating in Japan, Towa Pharmaceutical Co., Ltd. and its subsidiaries are engaged in the research, development, production, and sale of prescription drugs, active pharmaceutical ingredients, and intermediates. The company's extensive portfolio addresses critical therapeutic areas such as diabetes, digestive health, neurological conditions, and allergic diseases, alongside offering vitamins, antibiotics, and oncology treatments. With approximately 700 different drug products, Towa Pharmaceutical Co., Ltd. was established in 1951 and is headquartered in Osaka, Japan.
Towa Pharmaceutical Co., Ltd. is most often compared with the following Healthcare names: